The Oncology Institute, Inc. TOI Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s contract liabilities?
- The Oncology Institute, Inc. (TOI) reported contract liabilities of $0 in Q1 2026.
- How has The Oncology Institute, Inc.'s contract liabilities changed year-over-year?
- The Oncology Institute, Inc.'s contract liabilities decreased by 100.0% year-over-year, from $4.08M to $0.
- What is the long-term trend for The Oncology Institute, Inc.'s contract liabilities?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s contract liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $220K to $0.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.